Diabetes Drug Improving Glucose Control
Diabetes has totally engulfed the entire world with its ill effects and one can see the huge number of remedies for it. Type 2 Diabetes patients have high sugar level in their blood. A latest kind of drug can promise for reducing the glucose level to a certain point. TAK-875 is the drug which is going to increase the level of insulin from the pancreatic B cells. Fatty acids and glucose rise in blood soon after the meal and hence this particular drug can work at that particular time.
TAK-875 is a new kind of drug for treating type 2 diabetes and which controls blood sugar. This particular kind of drug will prevent in higher drop of blood sugar and which is known as hypoglycemia. A new study revealed the use of this particular drug and the unique feature of it.
Type 2 diabetes is a very common kind of diabetes in the present time. Around 90% out of 150 million from United States are suffering from this particular kind of problem. This particular kind of problem is due to lack of insulin and which in turn leads to heavy blood sugar. Lack of insulin can also cause other chronic problems.
GPR40 is very much responsible for the production rate of insulin. GPR40 mainly works by increasing insulin from the pancreatic B cells, when the fatty acids and glucose levels are raised soon after the meal. The glucose levels are then reduced. Drugs that can activate FFAR1 receptor can help for diabetics and release more amount of insulin.
TAK-875 is a best oral medicine and which helps in secretion of more insulin depending on the amount of glucose level.
- Diabetes Drug To Reduce Risk Of Cancer
- Alcohol And Diabetes – What You Need To Know
- Halozyme Therapeutics, Inc. (HALO) Positive Results Of Ultrafast Insulin Phase 2 Trials
- Decaffeinated Coffee To Reduce The Risk Of Diabetes And Improve Memory
- Tear Drops In Assessing Blood Sugar Levels
- New Approved Drug For Skin Cancer
- Prevent Diabetes: Eat Fish
- Heart Failure As One Of The Causes Of Diabetes
- New Discovery: A Molecule That Prevents Type 1 Diabetes In Mice